• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.Ras在Bcr-Abl癌基因对成纤维细胞和造血细胞转化中的遗传需求。
J Exp Med. 1995 Jan 1;181(1):307-13. doi: 10.1084/jem.181.1.307.
2
The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation.Bcr-Abl白血病致癌基因激活Jun激酶,且转化过程需要Jun。
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11746-50. doi: 10.1073/pnas.92.25.11746.
3
Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.
Cell. 1995 Sep 22;82(6):981-8. doi: 10.1016/0092-8674(95)90277-5.
4
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.BCR/ABL对造血细胞的转化需要激活PI-3k/Akt依赖的信号通路。
EMBO J. 1997 Oct 15;16(20):6151-61. doi: 10.1093/emboj/16.20.6151.
5
BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.BCR-ABL诱导的肿瘤发生是通过与GRB-2衔接蛋白的SH2结构域直接相互作用介导的。
Cell. 1993 Oct 8;75(1):175-85.
6
Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.p210bcr/abl对p120GAP GTP酶促进活性的负调控:对RAS依赖的费城染色体阳性细胞生长的影响
J Exp Med. 1994 Jun 1;179(6):1855-65. doi: 10.1084/jem.179.6.1855.
7
The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.BCR/ABL癌基因的P190、P210和P230形式在小鼠中诱导出类似慢性髓性白血病的综合征,但具有不同的淋巴细胞白血病致瘤活性。
J Exp Med. 1999 May 3;189(9):1399-412. doi: 10.1084/jem.189.9.1399.
8
Mutant forms of growth factor-binding protein-2 reverse BCR-ABL-induced transformation.生长因子结合蛋白-2的突变形式可逆转BCR-ABL诱导的细胞转化。
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10889-93. doi: 10.1073/pnas.92.24.10889.
9
Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant.线粒体中组成型激活的Raf-1的表达可恢复转化缺陷型BCR/ABL突变体的抗凋亡和致白血病潜能。
J Exp Med. 1998 Jun 15;187(12):1995-2007. doi: 10.1084/jem.187.12.1995.
10
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis.TLS/FUS是一种参与多种染色体易位的原癌基因,是BCR/ABL介导的白血病发生的新型调节因子。
EMBO J. 1998 Aug 3;17(15):4442-55. doi: 10.1093/emboj/17.15.4442.

引用本文的文献

1
Cytological Diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.经典骨髓增殖性肿瘤的细胞形态学诊断:分子生物学时代
Cells. 2023 Mar 20;12(6):946. doi: 10.3390/cells12060946.
2
Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis.利用 CRISPR/Cas9 介导的 BCR 和 ABL1 基因双切割构建费城染色体模型,模拟白血病发生的初始事件。
Cancer Gene Ther. 2023 Jan;30(1):38-50. doi: 10.1038/s41417-022-00522-w. Epub 2022 Aug 23.
3
Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future.慢性髓性白血病:过去、现在和未来的典范疾病。
Cells. 2021 Jan 10;10(1):117. doi: 10.3390/cells10010117.
4
NHD2-15, a novel antagonist of Growth Factor Receptor-Bound Protein-2 (GRB2), inhibits leukemic proliferation.NHD2-15,一种生长因子受体结合蛋白-2(GRB2)的新型拮抗剂,可抑制白血病增殖。
PLoS One. 2020 Aug 11;15(8):e0236839. doi: 10.1371/journal.pone.0236839. eCollection 2020.
5
Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells.癌细胞中对小分子抑制剂的继发性耐药突变
Cancers (Basel). 2020 Apr 9;12(4):927. doi: 10.3390/cancers12040927.
6
Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia.ZNF224在慢性髓性白血病中对c-Myc的抑制作用及对伊马替尼的反应性
Oncotarget. 2017 Dec 15;9(3):3417-3431. doi: 10.18632/oncotarget.23283. eCollection 2018 Jan 9.
7
RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.RAS 通路突变作为预测儿童 B 细胞前体急性淋巴细胞白血病治疗适应性的生物标志物。
Leukemia. 2018 Apr;32(4):931-940. doi: 10.1038/leu.2017.303. Epub 2017 Oct 3.
8
Apoptotic Effects of Farnesyltransferase blockade in Acute Myeloid Leukemia Cells.法尼基转移酶阻断对急性髓系白血病细胞的凋亡作用
Transl Med UniSa. 2016 Nov 1;15:22-33. eCollection 2016 Nov.
9
miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.微小RNA-101通过下调Jak2和抑制核因子κB靶基因使K562细胞系对伊马替尼敏感。
Tumour Biol. 2016 Oct;37(10):14117-14128. doi: 10.1007/s13277-016-5205-9. Epub 2016 Aug 12.
10
Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways.伴有 inv(3)/t(3;3) 的髓系恶性肿瘤的突变谱揭示了 RAS/RTK 信号通路的主要参与。
Blood. 2015 Jan 1;125(1):133-9. doi: 10.1182/blood-2014-07-591461. Epub 2014 Nov 7.

本文引用的文献

1
Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.人类 Sos1:一种与GRB2结合的Ras鸟嘌呤核苷酸交换因子。
Science. 1993 May 28;260(5112):1338-43. doi: 10.1126/science.8493579.
2
The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.哺乳动物Grb2的SH2和SH3结构域将表皮生长因子(EGF)受体与Ras激活剂mSos1偶联起来。
Nature. 1993 May 6;363(6424):83-5. doi: 10.1038/363083a0.
3
An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias.肌动蛋白结合功能有助于费城染色体阳性人类白血病的Bcr-Abl癌蛋白介导的细胞转化。
EMBO J. 1993 Apr;12(4):1533-46. doi: 10.1002/j.1460-2075.1993.tb05797.x.
4
SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.P210 BCR/ABL的SH1结构域自身磷酸化是细胞转化所必需的,但并非生长因子非依赖性所必需。
Mol Cell Biol. 1993 Mar;13(3):1728-36. doi: 10.1128/mcb.13.3.1728-1736.1993.
5
BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein.BCR-ABL诱导的肿瘤发生是通过与GRB-2衔接蛋白的SH2结构域直接相互作用介导的。
Cell. 1993 Oct 8;75(1):175-85.
6
Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders.1型神经纤维瘤病合并恶性髓系疾病患儿骨髓中正常NF1等位基因的缺失。
N Engl J Med. 1994 Mar 3;330(9):597-601. doi: 10.1056/NEJM199403033300903.
7
A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins.Bcr的卷曲螺旋寡聚化结构域对于Bcr-Abl癌蛋白的转化功能至关重要。
Mol Cell Biol. 1993 Dec;13(12):7587-95. doi: 10.1128/mcb.13.12.7587-7595.1993.
8
How receptor tyrosine kinases activate Ras.受体酪氨酸激酶如何激活Ras。
Trends Biochem Sci. 1993 Aug;18(8):273-5. doi: 10.1016/0968-0004(93)90031-h.
9
Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.通过将Raf靶向质膜可克服Ras对Raf激活的需求。
Nature. 1994 Jun 2;369(6479):411-4. doi: 10.1038/369411a0.
10
Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.p210bcr/abl对p120GAP GTP酶促进活性的负调控:对RAS依赖的费城染色体阳性细胞生长的影响
J Exp Med. 1994 Jun 1;179(6):1855-65. doi: 10.1084/jem.179.6.1855.

Ras在Bcr-Abl癌基因对成纤维细胞和造血细胞转化中的遗传需求。

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.

作者信息

Sawyers C L, McLaughlin J, Witte O N

机构信息

Department of Medicine, Hematology-Oncology, University of California at Los Angeles 90024.

出版信息

J Exp Med. 1995 Jan 1;181(1):307-13. doi: 10.1084/jem.181.1.307.

DOI:10.1084/jem.181.1.307
PMID:7807010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2191855/
Abstract

To determine the functional importance of Ras in transformation by Abl oncogenes, we used a genetic approach to measure the effect of impaired Ras activity on the ability of Bcr-Abl or v-Abl to transform cells. Expression of the catalytic domain of the GTPase activating protein for Ras (Gap C terminus) impaired soft agar colony formation by fibroblasts expressing v-Abl or Bcr-Abl by 70-80%. To test Ras function in a model that more closely resembles clinical diseases involving Bcr-Abl, double gene retroviruses expressing Bcr-Abl paired with the Gap C terminus or dominant negative Ras were introduced into naive mouse bone marrow cells. Transformation by Bcr-Abl was completely blocked in both situations. Coexpression of normal c-H-Ras accelerated the transforming activity of Bcr-Abl. These findings show that Ras activation is essential for the leukemogenic activity of Abl oncogenes in two distinct model systems. The results genetically define a connection between the Bcr-Abl cytoplasmic tyrosine kinase and Ras and add to the accumulating evidence that deregulation of Ras is a central event in the genesis of a number of molecularly distinct forms of human myeloid leukemia.

摘要

为了确定Ras在Abl癌基因介导的细胞转化中的功能重要性,我们采用遗传学方法来检测Ras活性受损对Bcr-Abl或v-Abl转化细胞能力的影响。Ras的GTP酶激活蛋白催化结构域(Gap C末端)的表达使表达v-Abl或Bcr-Abl的成纤维细胞在软琼脂中的集落形成能力受损70%-80%。为了在更类似于涉及Bcr-Abl的临床疾病的模型中测试Ras功能,将表达Bcr-Abl并与Gap C末端或显性负性Ras配对的双基因逆转录病毒导入未经处理的小鼠骨髓细胞。在这两种情况下,Bcr-Abl介导的转化均被完全阻断。正常c-H-Ras的共表达加速了Bcr-Abl的转化活性。这些发现表明,在两个不同的模型系统中,Ras激活对于Abl癌基因的致白血病活性至关重要。这些结果从遗传学上定义了Bcr-Abl细胞质酪氨酸激酶与Ras之间的联系,并进一步证明了Ras失调是多种分子特征不同的人类髓系白血病发生过程中的核心事件。